Antonis A. Armoundas, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Body Surface Potential Mapping | 14 | 2019 | 238 | 3.690 |
Why?
|
| Arrhythmias, Cardiac | 25 | 2023 | 2268 | 3.600 |
Why?
|
| Heart Conduction System | 18 | 2020 | 1047 | 3.170 |
Why?
|
| Tachycardia, Ventricular | 21 | 2022 | 1273 | 2.740 |
Why?
|
| Electrocardiography | 25 | 2021 | 6442 | 2.730 |
Why?
|
| Signal Processing, Computer-Assisted | 16 | 2020 | 1534 | 2.380 |
Why?
|
| Myocytes, Cardiac | 18 | 2020 | 1637 | 2.070 |
Why?
|
| Vagus Nerve Stimulation | 3 | 2023 | 199 | 1.950 |
Why?
|
| Mitochondria, Heart | 4 | 2018 | 247 | 1.850 |
Why?
|
| Models, Cardiovascular | 16 | 2017 | 996 | 1.670 |
Why?
|
| Membrane Potential, Mitochondrial | 4 | 2023 | 297 | 1.590 |
Why?
|
| Action Potentials | 13 | 2021 | 1806 | 1.550 |
Why?
|
| Death, Sudden, Cardiac | 9 | 2019 | 1541 | 1.530 |
Why?
|
| Electrocardiography, Ambulatory | 4 | 2020 | 585 | 1.510 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 5 | 2014 | 493 | 1.340 |
Why?
|
| Heart Rate | 11 | 2023 | 4091 | 1.270 |
Why?
|
| Cardiac Pacing, Artificial | 5 | 2021 | 845 | 1.160 |
Why?
|
| Monitoring, Physiologic | 3 | 2019 | 1738 | 1.140 |
Why?
|
| Heart | 13 | 2024 | 4467 | 1.140 |
Why?
|
| Sarcoplasmic Reticulum | 6 | 2016 | 158 | 1.120 |
Why?
|
| Calcium | 11 | 2019 | 5756 | 1.080 |
Why?
|
| Catheter Ablation | 11 | 2021 | 2758 | 1.000 |
Why?
|
| Algorithms | 26 | 2022 | 13881 | 0.990 |
Why?
|
| Tidal Volume | 3 | 2019 | 490 | 0.970 |
Why?
|
| Swine | 18 | 2021 | 5917 | 0.940 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2023 | 944 | 0.890 |
Why?
|
| Fractals | 1 | 2023 | 123 | 0.850 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 4 | 2020 | 127 | 0.840 |
Why?
|
| Pulmonary Ventilation | 2 | 2014 | 373 | 0.830 |
Why?
|
| Myocardial Ischemia | 4 | 2023 | 2148 | 0.800 |
Why?
|
| Mitochondria | 5 | 2023 | 3520 | 0.790 |
Why?
|
| Defibrillators, Implantable | 5 | 2015 | 1440 | 0.780 |
Why?
|
| Refractory Period, Electrophysiological | 1 | 2020 | 39 | 0.750 |
Why?
|
| Photoplethysmography | 1 | 2020 | 56 | 0.750 |
Why?
|
| Ventricular Fibrillation | 5 | 2013 | 538 | 0.730 |
Why?
|
| Respiratory Rate | 3 | 2019 | 162 | 0.710 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2021 | 161 | 0.680 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 6 | 2020 | 176 | 0.670 |
Why?
|
| Heart Atria | 3 | 2023 | 1357 | 0.660 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 236 | 0.640 |
Why?
|
| Oximetry | 1 | 2020 | 471 | 0.590 |
Why?
|
| Atrial Fibrillation | 4 | 2023 | 5034 | 0.570 |
Why?
|
| Cardiac Resynchronization Therapy | 2 | 2021 | 531 | 0.570 |
Why?
|
| Ventricular Function | 4 | 2009 | 416 | 0.560 |
Why?
|
| Heart Ventricles | 8 | 2020 | 3821 | 0.510 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 2214 | 0.510 |
Why?
|
| Data Mining | 1 | 2020 | 537 | 0.500 |
Why?
|
| Bioelectric Energy Sources | 1 | 2014 | 17 | 0.490 |
Why?
|
| Sodium-Calcium Exchanger | 4 | 2016 | 91 | 0.490 |
Why?
|
| Guinea Pigs | 6 | 2018 | 1386 | 0.470 |
Why?
|
| Calcium Channels, L-Type | 2 | 2013 | 240 | 0.470 |
Why?
|
| Cardiovascular Diseases | 4 | 2024 | 15165 | 0.470 |
Why?
|
| Respiratory System | 1 | 2017 | 557 | 0.460 |
Why?
|
| Reactive Oxygen Species | 3 | 2018 | 2077 | 0.460 |
Why?
|
| Medicine | 1 | 2022 | 946 | 0.450 |
Why?
|
| Electric Countershock | 1 | 2015 | 534 | 0.410 |
Why?
|
| Animals | 46 | 2022 | 168757 | 0.400 |
Why?
|
| Calsequestrin | 3 | 2020 | 30 | 0.400 |
Why?
|
| Heart Failure | 9 | 2021 | 10900 | 0.400 |
Why?
|
| Heart Diseases | 1 | 2024 | 2788 | 0.380 |
Why?
|
| Fourier Analysis | 1 | 2011 | 447 | 0.370 |
Why?
|
| Catecholamines | 2 | 2015 | 387 | 0.370 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 2025 | 0.370 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 1813 | 0.360 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 1831 | 0.350 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2020 | 719 | 0.340 |
Why?
|
| American Heart Association | 2 | 2024 | 1056 | 0.330 |
Why?
|
| Oxygen | 1 | 2020 | 4189 | 0.330 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 1177 | 0.320 |
Why?
|
| Biological Clocks | 1 | 2010 | 321 | 0.310 |
Why?
|
| Myocardial Infarction | 4 | 2023 | 11727 | 0.310 |
Why?
|
| Up-Regulation | 2 | 2020 | 4217 | 0.310 |
Why?
|
| Receptors, Catecholamine | 1 | 2007 | 6 | 0.300 |
Why?
|
| Autonomic Nervous System | 4 | 2023 | 671 | 0.300 |
Why?
|
| Dogs | 7 | 2011 | 3912 | 0.270 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 1585 | 0.270 |
Why?
|
| Stochastic Processes | 4 | 2017 | 344 | 0.270 |
Why?
|
| Primary Prevention | 1 | 2013 | 1167 | 0.270 |
Why?
|
| Lung | 3 | 2014 | 9856 | 0.270 |
Why?
|
| Energy Metabolism | 1 | 2017 | 2899 | 0.260 |
Why?
|
| Reproducibility of Results | 10 | 2022 | 19905 | 0.250 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 18029 | 0.250 |
Why?
|
| Computer Simulation | 12 | 2013 | 6196 | 0.250 |
Why?
|
| Quality Improvement | 1 | 2020 | 3749 | 0.250 |
Why?
|
| Risk Assessment | 8 | 2013 | 23338 | 0.240 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 1257 | 0.240 |
Why?
|
| Myocardium | 4 | 2015 | 4776 | 0.240 |
Why?
|
| Time Factors | 8 | 2021 | 40075 | 0.240 |
Why?
|
| Stroke | 2 | 2024 | 9981 | 0.230 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6487 | 0.230 |
Why?
|
| Humans | 51 | 2024 | 744343 | 0.230 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2013 | 1018 | 0.220 |
Why?
|
| Predictive Value of Tests | 9 | 2014 | 15076 | 0.220 |
Why?
|
| Nonlinear Dynamics | 4 | 2016 | 502 | 0.220 |
Why?
|
| Electrodes | 2 | 2016 | 619 | 0.210 |
Why?
|
| Pericardium | 1 | 2006 | 667 | 0.210 |
Why?
|
| Mitochondrial Membranes | 1 | 2023 | 175 | 0.200 |
Why?
|
| Potassium Channels | 4 | 2008 | 563 | 0.200 |
Why?
|
| Models, Biological | 4 | 2018 | 9583 | 0.200 |
Why?
|
| Signal Transduction | 6 | 2018 | 23403 | 0.200 |
Why?
|
| Ventricular Remodeling | 2 | 2015 | 1224 | 0.190 |
Why?
|
| Electrophysiological Phenomena | 2 | 2014 | 315 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2012 | 2073 | 0.190 |
Why?
|
| Vagus Nerve | 1 | 2023 | 438 | 0.190 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8949 | 0.190 |
Why?
|
| Technology Transfer | 1 | 2020 | 44 | 0.180 |
Why?
|
| Calcium Signaling | 3 | 2020 | 721 | 0.180 |
Why?
|
| Electrophysiology | 3 | 2003 | 1308 | 0.180 |
Why?
|
| Wireless Technology | 1 | 2020 | 100 | 0.180 |
Why?
|
| Torsades de Pointes | 1 | 2000 | 78 | 0.170 |
Why?
|
| Potassium Channels, Voltage-Gated | 3 | 2005 | 142 | 0.170 |
Why?
|
| Random Allocation | 2 | 2014 | 2429 | 0.170 |
Why?
|
| Models, Animal | 3 | 2014 | 2171 | 0.160 |
Why?
|
| Ion Channels | 2 | 2015 | 1056 | 0.160 |
Why?
|
| Male | 25 | 2021 | 350118 | 0.160 |
Why?
|
| Sensitivity and Specificity | 8 | 2014 | 14722 | 0.160 |
Why?
|
| Sus scrofa | 1 | 2020 | 437 | 0.160 |
Why?
|
| Computers | 1 | 2020 | 612 | 0.160 |
Why?
|
| Muscle Cells | 2 | 2011 | 197 | 0.150 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2020 | 274 | 0.150 |
Why?
|
| Disease-Free Survival | 4 | 2015 | 6895 | 0.150 |
Why?
|
| Oxidative Stress | 2 | 2023 | 3086 | 0.140 |
Why?
|
| Polysomnography | 1 | 2023 | 1776 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2024 | 832 | 0.140 |
Why?
|
| Heart Function Tests | 1 | 2017 | 330 | 0.140 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4328 | 0.140 |
Why?
|
| Homeostasis | 1 | 2007 | 3340 | 0.130 |
Why?
|
| Models, Genetic | 1 | 2006 | 3494 | 0.130 |
Why?
|
| Periodicity | 1 | 2017 | 363 | 0.130 |
Why?
|
| Hand | 1 | 2020 | 884 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2023 | 1099 | 0.130 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2015 | 246 | 0.120 |
Why?
|
| Pyruvic Acid | 1 | 2015 | 200 | 0.120 |
Why?
|
| Organelles | 1 | 2016 | 264 | 0.120 |
Why?
|
| Permeability | 1 | 2016 | 738 | 0.120 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 2187 | 0.110 |
Why?
|
| Cyclosporine | 1 | 2016 | 786 | 0.110 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 1616 | 0.110 |
Why?
|
| Brugada Syndrome | 1 | 2013 | 97 | 0.110 |
Why?
|
| Exercise Test | 1 | 2020 | 2074 | 0.110 |
Why?
|
| Models, Anatomic | 3 | 2008 | 691 | 0.100 |
Why?
|
| Endotoxemia | 1 | 2013 | 207 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2021 | 63114 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 1970 | 0.100 |
Why?
|
| Cells, Cultured | 5 | 2020 | 19229 | 0.100 |
Why?
|
| Kv Channel-Interacting Proteins | 2 | 2008 | 56 | 0.100 |
Why?
|
| Electricity | 1 | 2011 | 182 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2018 | 2715 | 0.090 |
Why?
|
| Models, Statistical | 2 | 2003 | 5102 | 0.090 |
Why?
|
| Sodium | 2 | 2008 | 1623 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 2699 | 0.090 |
Why?
|
| Papillary Muscles | 1 | 2010 | 203 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 1917 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2015 | 1133 | 0.090 |
Why?
|
| Metabolome | 1 | 2016 | 895 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 1081 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1184 | 0.090 |
Why?
|
| Adipose Tissue, Brown | 1 | 2015 | 757 | 0.080 |
Why?
|
| Survival Rate | 2 | 2015 | 12788 | 0.080 |
Why?
|
| Cytosol | 1 | 2011 | 901 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3679 | 0.080 |
Why?
|
| Cardiomyopathies | 2 | 2015 | 1912 | 0.080 |
Why?
|
| Axons | 1 | 2016 | 1684 | 0.080 |
Why?
|
| Ablation Techniques | 1 | 2010 | 249 | 0.080 |
Why?
|
| Sleep | 1 | 2023 | 4623 | 0.070 |
Why?
|
| Catheters | 2 | 2021 | 425 | 0.070 |
Why?
|
| Middle Aged | 7 | 2021 | 213383 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2021 | 3265 | 0.070 |
Why?
|
| Organometallic Compounds | 1 | 2010 | 665 | 0.070 |
Why?
|
| Long QT Syndrome | 2 | 2002 | 453 | 0.070 |
Why?
|
| Reference Values | 2 | 2012 | 4982 | 0.070 |
Why?
|
| Synapses | 1 | 2016 | 1728 | 0.070 |
Why?
|
| Mutation | 3 | 2015 | 29786 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2015 | 2132 | 0.070 |
Why?
|
| Female | 12 | 2021 | 380194 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 4266 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2008 | 349 | 0.070 |
Why?
|
| Stroke Volume | 2 | 2012 | 5007 | 0.070 |
Why?
|
| Thorax | 2 | 2006 | 547 | 0.070 |
Why?
|
| Prognosis | 4 | 2012 | 29063 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 1990 | 0.060 |
Why?
|
| Isoproterenol | 2 | 2015 | 399 | 0.060 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2006 | 195 | 0.060 |
Why?
|
| Aged | 6 | 2021 | 163280 | 0.060 |
Why?
|
| Ethanol | 1 | 2010 | 1342 | 0.060 |
Why?
|
| Inflammation | 1 | 2023 | 10638 | 0.060 |
Why?
|
| Recurrence | 2 | 2010 | 8340 | 0.060 |
Why?
|
| Physicians | 1 | 2022 | 4567 | 0.060 |
Why?
|
| Software | 1 | 2018 | 4443 | 0.060 |
Why?
|
| Rabbits | 2 | 2006 | 4894 | 0.060 |
Why?
|
| Glucose | 1 | 2015 | 4397 | 0.050 |
Why?
|
| Sheep, Domestic | 1 | 2022 | 49 | 0.050 |
Why?
|
| Tachycardia | 1 | 2005 | 619 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2010 | 1491 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2008 | 2716 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 6538 | 0.050 |
Why?
|
| Pacemaker, Artificial | 1 | 2006 | 816 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 1998 | 1782 | 0.050 |
Why?
|
| Abdomen | 1 | 2006 | 1118 | 0.050 |
Why?
|
| Bundle-Branch Block | 1 | 2002 | 270 | 0.050 |
Why?
|
| Reoperation | 1 | 2010 | 4201 | 0.050 |
Why?
|
| Quality Control | 1 | 2003 | 841 | 0.050 |
Why?
|
| Reperfusion | 1 | 2021 | 284 | 0.040 |
Why?
|
| Mice | 5 | 2021 | 81183 | 0.040 |
Why?
|
| Sheep | 1 | 2022 | 1437 | 0.040 |
Why?
|
| Intraoperative Care | 1 | 2003 | 767 | 0.040 |
Why?
|
| RNA Interference | 1 | 2008 | 2889 | 0.040 |
Why?
|
| United States | 2 | 2024 | 69872 | 0.040 |
Why?
|
| Diastole | 1 | 2021 | 791 | 0.040 |
Why?
|
| Neurons | 1 | 2018 | 9338 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2008 | 3508 | 0.040 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2021 | 475 | 0.040 |
Why?
|
| Disease Progression | 1 | 2014 | 13284 | 0.040 |
Why?
|
| Adult | 4 | 2020 | 214055 | 0.040 |
Why?
|
| Wavelet Analysis | 1 | 2016 | 57 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2373 | 0.040 |
Why?
|
| Baroreflex | 1 | 1997 | 146 | 0.040 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2015 | 88 | 0.030 |
Why?
|
| Shal Potassium Channels | 2 | 2005 | 21 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 1997 | 454 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2003 | 1774 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 21827 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 56430 | 0.030 |
Why?
|
| KCNQ Potassium Channels | 2 | 2005 | 18 | 0.030 |
Why?
|
| Data Collection | 1 | 2023 | 3341 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2015 | 10252 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2015 | 8436 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 346 | 0.030 |
Why?
|
| Databases as Topic | 1 | 2016 | 475 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 569 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39050 | 0.030 |
Why?
|
| KCNQ1 Potassium Channel | 2 | 2005 | 104 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2003 | 5078 | 0.030 |
Why?
|
| Markov Chains | 1 | 2016 | 969 | 0.030 |
Why?
|
| Systems Biology | 1 | 2016 | 469 | 0.030 |
Why?
|
| Phantoms, Imaging | 2 | 2013 | 2480 | 0.030 |
Why?
|
| Guanylate Cyclase | 1 | 2013 | 201 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 625 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15540 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 2013 | 409 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 3778 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 1682 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 535 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 783 | 0.030 |
Why?
|
| Risk Factors | 2 | 2012 | 72290 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4931 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2016 | 2557 | 0.020 |
Why?
|
| Troponin I | 1 | 2015 | 619 | 0.020 |
Why?
|
| Peptides | 1 | 2003 | 4409 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 2731 | 0.020 |
Why?
|
| Linear Models | 2 | 1999 | 5952 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 53288 | 0.020 |
Why?
|
| Sarcomeres | 1 | 2013 | 374 | 0.020 |
Why?
|
| Potassium | 2 | 2005 | 1336 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 57776 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 7913 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2015 | 14557 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 996 | 0.020 |
Why?
|
| Cysteine | 1 | 2013 | 874 | 0.020 |
Why?
|
| Swine, Miniature | 1 | 2010 | 961 | 0.020 |
Why?
|
| Fibrosis | 1 | 2015 | 2029 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2008 | 280 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2008 | 379 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 15295 | 0.020 |
Why?
|
| Injections | 1 | 2010 | 840 | 0.020 |
Why?
|
| Blood Pressure | 3 | 2015 | 8554 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2503 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2216 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 964 | 0.020 |
Why?
|
| Kv1.4 Potassium Channel | 1 | 2005 | 3 | 0.020 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2005 | 70 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2008 | 959 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 4669 | 0.010 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2005 | 150 | 0.010 |
Why?
|
| Flecainide | 1 | 2003 | 42 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 9734 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2008 | 2726 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 12072 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2015 | 5985 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2010 | 1422 | 0.010 |
Why?
|
| Gene Expression | 2 | 2005 | 7799 | 0.010 |
Why?
|
| Equipment Design | 1 | 2008 | 3582 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 1406 | 0.010 |
Why?
|
| Species Specificity | 1 | 2003 | 2478 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2003 | 789 | 0.010 |
Why?
|
| Renal Circulation | 1 | 1999 | 333 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 2472 | 0.010 |
Why?
|
| Rats | 2 | 2008 | 24260 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2002 | 1549 | 0.010 |
Why?
|
| Blood Circulation | 1 | 1997 | 251 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1997 | 378 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 5892 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 15997 | 0.010 |
Why?
|
| Feedback | 1 | 1997 | 795 | 0.010 |
Why?
|
| Posture | 1 | 1997 | 958 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 2003 | 3107 | 0.010 |
Why?
|
| Artifacts | 1 | 1999 | 1904 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1998 | 77449 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 13033 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 8301 | 0.000 |
Why?
|
| Phenotype | 1 | 2003 | 16365 | 0.000 |
Why?
|